Scheme

Aditya Birla Sun Life Pharma Healthcare Fund

Holds 39 companies worth ₹1,055 Cr in Sept 2026.

  • Fund house

    Aditya BirlaThe fund house that runs this scheme.
  • AUM

    ₹1,078 CrAditya Birla Sun Life Pharma Healthcare Fund's AUM at the end of 30 Sept 2026, as AMFI reports it. Down 2.3% on Aug 2026, ₹1,103 Cr.
  • Largest holding

    Torrent Pharmaceuticals LimitedTorrent Pharmaceuticals Limited is 9.3% of this scheme's NAV.
  • Fund manager

    Dhaval ShahRuns it since 11 Jul 2019, as the fund house dates it.

AUM(Sept 2019 – Sept 2026)

AUM at month end each month, and its change on the month before
12 months₹ CrChange
Sept 20261,078−2.3%
Aug 20261,103+2.7%
Jul 20261,074+6.3%
Jun 20261,011+6.4%
May 2026950+5.5%
Apr 2026901+4.9%
Mar 2026859+0.6%
Feb 2026854+5.1%
Jan 2026813−2.9%
Dec 2025837−1.9%
Nov 2025854+0.8%
Oct 2025847+2.1%
AUM at month end, Sept 2026
₹1,078 Cr
+27.2% since Oct 2025
Fig. 1.AUM at each month's end, ₹ crore; under All, the quarterly average since 2010. Source: AMFI.

Direct plans(Sept 2019 – Sept 2026)

Direct plans' share of AUM each quarter, and its change on the quarter before
4 quartersShareChange
Sept 202620.64%+0.84 pt
Jun 202619.80%+2.47 pt
Mar 202617.33%+0.59 pt
Dec 202516.75%+0.22 pt
Direct plans' share of AUM, Sept 2026
20.64%
+3.89 pt since Dec 2025
Fig. 2.Aditya Birla Sun Life Pharma Healthcare Fund's quarterly average AUM in direct plans, which pay no distributor; changes in points. Source: AMFI.

Returns(9 Oct 2026)

Growth · Direct and Regular plans

To 9 Oct 2026; past a year, a yearly rate. Benchmark: BSE Healthcare TRI. * From NAVs. Source: AMFI. Click a column's header to sort by it.
1 month *
−5.27%−5.38%––−4.51%
3 months *
−1.73%−2.04%––−3.15%
6 months *
+14.71%+13.98%––+4.22%
1 year
+13.34%+11.88%+10.89%+2.44 pt+0.43%
3 years
+19.80%+18.22%+21.02%−1.22 pt+12.61%
5 years
+13.47%+11.91%+13.93%−0.46 pt+11.64%
Since launch
+20.49%+18.69%+21.15%−0.66 pt+13.17%
Fig. 3.To 9 Oct 2026; past a year, a yearly rate. Benchmark: BSE Healthcare TRI. * From NAVs. Source: AMFI.